4
Changes in Ownership
Denali Therapeutics Inc. Filed Acc 0001209191-17-065240
President and CEO acquired 12,500 shares (conversion)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Watts Ryan J. President and CEO | 2017-12-12 | Conversion | +12,500 | 12,500 | D | ||
| Derivatives | |||||||
| Watts Ryan J. President and CEO | 2017-12-12 | Conversion · Series B-1 Preferred Stock | −12,500 | 0 | D | ||
Loading xslF345X03/doc4.xml…